Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)

被引:25
|
作者
Asano, Yasutomi [1 ]
Kitamura, Shuji [1 ]
Ohra, Taiichi [1 ]
Aso, Kazuyoshi [1 ]
Igata, Hideki [3 ]
Tamura, Tomoko [3 ]
Kawamoto, Tomohiro [2 ]
Tanaka, Toshimasa [2 ]
Sogabe, Satoshi [2 ]
Matsumoto, Shin-ichi [2 ]
Yamaguchi, Masashi [2 ]
Kimura, Hiroyuki [2 ]
Itoh, Fumio [1 ]
机构
[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Med Chem Res Labs, Yodogawa Ku, Osaka 5328686, Japan
[2] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Discovery Res Ctr, Yodogawa Ku, Osaka 5328686, Japan
[3] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Pharmacol Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan
关键词
JNK; JNK inhibitor; isoquinolone; SAR; Modeling; heart failure; cardiac hypertrophy; X-ray crystallography;
D O I
10.1016/j.bmc.2008.02.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modi. cation at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4715 / 4732
页数:18
相关论文
共 50 条
  • [31] Synthesis and biological evaluation of novel bi-functional selective serotonin reuptake inhibitors
    Miranda, M. Graciela
    Pinney, Kevin G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [32] Discovery, optimization and biological evaluation of novel HBsAg production inhibitors
    Zhang, Li
    Ge, Xingfeng
    Jin, Hui
    Lu, Dandan
    Chen, Shuo
    Zhang, Yang
    Wang, Xiaojin
    Xu, Hongjiang
    Ao, Wangwei
    Zhang, Yinsheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 256
  • [33] Synthesis and biological evaluation of novel Ani9 derivatives as potent and selective ANO1 inhibitors
    Seo, Yohan
    Kim, Jinhwang
    Chang, Jiwon
    Kim, Seong Soon
    Namkung, Wan
    Kim, Ikyon
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 160 : 245 - 255
  • [34] NOVEL 1,2,4-OXADIAZOLE DERIVATIVES AS SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS: DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION
    Nazari, Maryam
    Rezaee, Elham
    Hariri, Roshanak
    Akbarzadeh, Tahmineh
    Tabatabai, Sayyed Abbas
    EXCLI JOURNAL, 2021, 20 : 907 - 921
  • [35] The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation
    Zhou, Yang
    Nie, Tao
    Zhang, Yan
    Song, Ming
    Li, Kuai
    Ding, Mengxiao
    Ding, Ke
    Wu, Donghai
    Xu, Yong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (18) : 4310 - 4317
  • [36] Discovery of adamantane ethers as inhibitors of 11β-HSD-1:: Synthesis and biological evaluation
    Patel, Jyoti R.
    Shuai, Qi
    Dinges, Jurgen
    Winn, Marty
    Pliushchev, Marina
    Fung, Steven
    Monzon, Katina
    Chiou, William
    Wang, Jiahong
    Pan, Liping
    Wagaw, Seble
    Engstrom, Kenneth
    Kerdesky, Francis A.
    Longenecker, Kenton
    Judge, Russell
    Qin, Wenying
    Imade, Hovis M.
    Stolarik, DeAnne
    Beno, David W. A.
    Brune, Michael
    Chovan, Linda E.
    Sham, Hing L.
    Jacobson, Peer
    Link, J. T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (03) : 750 - 755
  • [37] Discovery, Synthesis and Evaluation of Novel Cholesterol Absorption Inhibitors
    Zhu, Xiaoyun
    Ji, Jianfeng
    Huang, Dandan
    Zhu, Yan
    Tang, Chunlei
    Yang, Xuan
    Qian, Hai
    Huang, Wenlong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (03) : 426 - 433
  • [38] Discovery, synthesis and biological evaluation of pyrrole derivatives as novel and highly selective potassium-competitive acid blockers (P-CABs)
    Nishida, Haruyuki
    Hasuoka, Atsushi
    Arikawa, Yasuyoshi
    Kurasawa, Osamu
    Hirase, Keizo
    Inatomi, Nobuhiro
    Hori, Yasunobu
    Sato, Fumihiko
    Tarui, Naoki
    Imanishi, Akio
    Kondo, Mitsuyo
    Endo, Satoshi
    Takagi, Terufumi
    Kajino, Masahiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [39] Discovery, synthesis and biological evaluation of novel glucokinase activators
    McKerrecher, D
    Allen, JV
    Bowker, SS
    Boyd, S
    Caulkett, PWR
    Currie, GS
    Davies, CD
    Fenwick, ML
    Gaskin, H
    Grange, E
    Hargreaves, RB
    Hayter, BR
    James, R
    Johnson, KM
    Johnstone, C
    Jones, CD
    Lackie, S
    Rayner, JW
    Walker, RP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (08) : 2103 - 2106
  • [40] Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold
    Zhan, Mei-Miao
    Yang, Yang
    Luo, Jinfeng
    Zhang, Xing-Xing
    Xiao, Xuan
    Li, Shiyu
    Cheng, Kai
    Xie, Zhouling
    Tu, Zhengchao
    Liao, Chenzhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 724 - 731